$KVUE News
Last published 1w ago
- 1w ago.IXIC.SPX.DJIAAPL+9Cramer’s week ahead: Expect more volatility as tech earnings, midterms loomCNBCInvestors await earnings from Apple, AMD, and other major companies, as well as the midterm elections and the monthly jobs report.
- 1w agoSPGIKMBMGRCOKTA+5Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600PR NewswireNEW YORK, Oct. 30, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600 effective prior to the opening of trading on Wednesday,
- 1w agoKVUEKenvue Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoKVUEKenvue Reports Third Quarter 2026 ResultsBusiness WireDelivered Fourth Consecutive Quarter of Net and Organic Sales1 Growth Net Sales Increased 3.2%; Organic Sales Increased 2.9% Diluted EPS Increased 5% to $0.22; Adjusted Diluted EPS1 Increased 4% to
- 2w agoKMBKVUEKimberly-Clark Corporation Announces Extension of the Expiration Date for Exchange Offers for Kenvue NotesPR NewswireDALLAS, Oct. 27, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ:KMB) ("Kimberly-Clark") announced today the extension of the expiration date of the offers to exchange (each an "Exchange Offer"
- 3w agoKVUEKenvue to Announce Third Quarter 2026 Results on October 30, 2026Business WireKenvue Inc. (NYSE:KVUE) will announce its third quarter 2026 financial results before the market opens on October 30, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly
- 4w agoKMBKVUEKimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange OffersPR NewswireDALLAS, Oct. 13, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ:KMB) ("Kimberly-Clark") announced today that the requisite number of consents have been received to adopt certain proposed amendments (the
- 1mo agoKMBKVUEKimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership TeamPR NewswireKimberly-Clark Corporation (NASDAQ: KMB) today announced planned executive transitions and updates to the future leadership team for the company upon ...
- 1mo agoKVUELISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 BillionBusiness WireGlobal research shows oral disease case numbers rose more than 3% over four years, as researchers warn that progress is too slow to meet the WHO’s 2030 target. This World Smile Day, LISTERINE® is launching Oral
- 1mo agoKVUENeutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and HairBusiness WireResearch shared at the 35th European Academy of Dermatology and Venereology (EADV) Congress highlights the benefits of multifunctional sunscreens, colloidal oat formulations addressing acne, hyperpigmentation, eczema,
- 1mo agoKMBKVUEKimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue NotesPR NewswireKimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today the commencement, in connection with its previously announced pending...
- 2mo agoKVUEKenvue Declares Quarterly Cash DividendBusiness WireKenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock. The quarterly dividend is payable on October 2, 2026, to shareholders of record
- 3mo agoKMBKVUEKimberly-Clark Appoints Suzana Blades as Senior Vice President and General CounselPR NewswireAccomplished legal executive and global litigator brings proven track record of enterprise risk management and strategic leadership to support Kimberly-Clark's next chapter of growthDALLAS, Aug. 13, 2026
- 3mo agoKVUEKenvue Reports Second Quarter 2026 ResultsBusiness WireDelivered Third Consecutive Quarter of Net and Organic Sales1 Growth Net Sales Increased 3.0%; Organic Sales Increased 1.6% Diluted EPS Increased 9% to $0.24; Adjusted Diluted EPS1 Increased 7% to
- 3mo agoKVUEKenvue Increases Quarterly Cash DividendBusiness WireKenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly
- 3mo agoKVUEKenvue to Announce Second Quarter 2026 Results on August 6, 2026Business WireKenvue Inc. (NYSE:KVUE) will announce its second quarter 2026 financial results before the market opens on August 6, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly
- 4mo agoPEPSBUXSTZTJX+2Jim Cramer says these are the 5 stocks to buy during this market rotationCNBCCNBC's Jim Cramer said investors should use the latest market rotation as an opportunity to buy high-quality companies.
- 5mo ago.SPXNVDAGOOGLJPM+7Jim Cramer says look to buy these 5 stocks outside the AI trade for diversificationCNBCCNBC's Jim Cramer said investors should consider adding exposure to out-of-favor sectors if investors begin rotating away from high-flying technology stocks.
- 6mo agoKVUEKenvue Reports First Quarter 2026 ResultsBusiness WireNet Sales Increased 4.5%; Organic Sales1 Increased 0.7% Diluted EPS Increased 47% to $0.25; Adjusted Diluted EPS1 Increased 33% to $0.32 Kenvue Inc. (NYSE:KVUE) today announced financial results for the fiscal
- 6mo agoKVUEKenvue Declares Quarterly Cash DividendBusiness WireKenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on May 27, 2026, to shareholders of record as
- 6mo agoKVUEKenvue to Announce First Quarter 2026 Results on May 7, 2026Business WireKenvue Inc. (NYSE:KVUE) will announce its first quarter 2026 financial results before the market opens on May 7, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly
- 7mo agoKMBKVUEKimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key LeadershipPR NewswireKimberly‑Clark Corporation (NASDAQ: KMB) today announced the organizational structure and key leadership that will become effective upon completion...
- 8mo agoKVUEKenvue Reports Fourth Quarter and Full Year 2025 ResultsBusiness WireQ4 Net Sales 3.2%; Organic Sales1 1.2% Q4 Diluted EPS was $0.17; Adjusted Diluted EPS1 was $0.27 FY'25 Net Sales (2.1)%; Organic Sales (2.2)% FY'25 Diluted EPS was $0.76; Adjusted Diluted EPS was
- 9mo agoKVUEKenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026Business WireKenvue Inc. (NYSE:KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a
- 9mo agoKMBKVUEKimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of KenvuePR NewswireKimberly-Clark Corporation (NASDAQ: KMB) and Kenvue Inc. (NYSE: KVUE) today announced that Kimberly-Clark and Kenvue shareholders voted...
- 9mo agoKVUEKenvue Declares Quarterly Cash DividendBusiness WireKenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on February 25, 2026, to shareholders of
- 1y agoPLTRAMZNUBERYUM+4Palantir earnings, Pizza Hut's options, a new consumer staples giant and more in Morning SquawkCNBCHere are five key things investors need to know to start the trading day.
- 1y agoKVUEKMBKimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'CNBCKimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.
- 1y agoKVUEKVUE Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Kenvue to Kimberly-ClarkGlobeNewswireMONSEY, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Kenvue Inc. (NYSE:KVUE) ("Kenvue") to Kimberly-Clark pursuant to which
- 1y agoKVUEKMBJNJKimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giantCNBCThe combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.
- 1y agoKMBKVUEKimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness LeaderPR NewswireKimberly-Clark Corporation (NASDAQ: KMB), a global personal care leader, and Kenvue Inc. (NYSE: KVUE), a global consumer health leader, today...
- 1y agoKVUEKenvue Reports Third Quarter 2025 ResultsBusiness WireNet Sales (3.5)%; Organic Sales1 (4.4)% Diluted EPS was $0.21; Adjusted Diluted EPS1 was $0.28 Affirms Outlook for FY'25 Kirk Perry Named Permanent Chief Executive Officer and Company Announced Additional Key
- 1y agoKVUEKenvue Declares Quarterly Cash DividendBusiness WireKenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on November 26, 2025, to shareholders of
- 1y agoKVUEKenvue to Announce Third Quarter 2025 Results on November 6, 2025Business WireKenvue Inc. (NYSE:KVUE) will announce its third quarter 2025 financial results before the market opens on November 6, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its
- 1y agoKDPKVUEPZZADRIHow Starboard could build value at Keurig Dr Pepper ahead of its JDE Peet dealCNBCStarboard has taken a position in Keurig Dr Pepper and has held meetings with the company's management.
- 1y agoKVUEAlbert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AIBusiness WireFrontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE:KVUE), maker of consumer health products like Zyrtec®, Neutrogena®, and Listerine®, to accelerate
- 1y agoKVUETrump admin draws unproven link between autism and Tylenol ingredient use during pregnancyCNBCOfficials warned pregnant women against using acetaminophen unless they have a fever, and touted a lesser-known drug as a potential treatment for autism.
- 1y agoKVUETrump administration reportedly plans to link autism to Tylenol ingredient use in pregnancyCNBCFederal health officials also are expected to highlight leucovorin, a form of folate, as a potential autism treatment, according to The Washington Post.
- 1y agoKVUEKenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancyCNBCHHS will release the report that could draw that link between the pain medication and autism this month, according to the Wall Street Journal.
- 1y agoKVUEKenvue, Inc. (KVUE) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoKVUEKenvue Reports Second Quarter 2025 ResultsBusiness WireNet Sales (4.0)%; Organic Sales1 (4.2)% Diluted EPS was $0.22; Adjusted Diluted EPS1 was $0.29 Continues to Advance Ongoing Review of Strategic Alternatives, While Taking Actions to Accelerate Profitable Growth
- 1y agoKVUEKenvue Increases Quarterly Cash DividendBusiness WireKenvue Inc. (NYSE:KVUE) today announced its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly dividend.
- 1y agoKVUEKenvue to Announce Second Quarter 2025 Results on August 7, 2025Business WireKenvue Inc. (NYSE:KVUE) will announce its second quarter 2025 financial results before the market opens on August 7, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its
- 1y agoKVUEKenvue Announces CEO Transition and Actions to Unlock Shareholder ValueBusiness WireAppoints Current Kenvue Director and Proven CPG and Technology Company Leader, Kirk Perry, as Interim CEO, Effective Immediately Announces Ongoing Review of Strategic Alternatives Reports Select Preliminary
- 1y agoKVUEKenvue Debuts on Fortune 500 ListBusiness WireKenvue Inc. (NYSE:KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has made the prestigious Fortune 500 list for the first time since becoming a fully
- 1y agoKVUEKenvue Announces Participation in Deutsche Bank's dbAccess Global Consumer ConferenceBusiness WireKenvue Inc. (NYSE:KVUE), the maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol®, today announced the Company's participation in Deutsche Bank's dbAccess Global Consumer
- 1y agoKVUEEveryday Care in Action: Thousands of Kenvue Employees Come Together Across 21 Markets to Help Advance Healthier CommunitiesBusiness WireKenvuers contribute 5,000+ hours of volunteer time to local causes along with building 22,000+ hygiene kits for underserved communities Hygiene kits to feature 110,000+ donated products from iconic brands
- 1y agoKVUEKenvue Reports First Quarter 2025 ResultsBusiness WireNet Sales (3.9)%; Organic Sales1 (1.2)% Maintains Focus On Accelerating Profitable Growth and Optimizing Cost Structure, While Successfully Completing TSA Exits Updates Outlook for FY'25 for Incremental Tariff
- 1y agoKVUEKenvue Announces Chief Financial Officer TransitionBusiness WireAmit Banati, 30-Year Consumer Products Company Finance and Operations Veteran, Appointed CFO Succeeds Paul Ruh, Effective May 12, 2025 Kenvue Inc. (NYSE:KVUE), today announced the appointment of Amit Banati as the
- 1y agoKVUEKenvue to Announce First Quarter 2025 Results on May 8, 2025Business WireKenvue Inc. (NYSE:KVUE) will announce its first quarter 2025 financial results before market open on May 8, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial